Allogene Therapeutics, Inc.
ALLO$2.03▲ 1.50% 24h
Allogene Therapeutics, Inc.ALLO$2.03
+$0.2145(+11.81%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$494.87M
P/E ratio
—
EPS (diluted)
$-0.87
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$0
Net income
$-190.89M
Net margin
—
Gross margin
—
Dividends & financials
Allogene Therapeutics, Inc. (ALLO) reported revenue of $0 and net income of $-190.89M, or $-0.87 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.